Generics Market in Japan Poised for Strong Growth

According to our latest report, “Japanese Generic Market Forecast to 2013”, the generic drugs market in Japan has been growing at a fast pace over the past few years. Factors like rising awareness level among population, strong government support, and patent expiration of blockbuster branded drugs have all led to create a US$ 7.3 Billion worth generics market in 2009. There exists a large untapped potential in Japanese generics market that has been attracting major drug manufacturers to the country. It is expected that the market will perform well in future and will grow at a CAGR of around 8% during 2009-2013 to reach around US$ 10 Billion at the end of the period.

 

Our report has found that the share of ethical drugs is very high in the Japanese generics drug market. In 2009, with 92.4% share, ethical generics dominated the overall market as compared to OTC generics. The expansion of NHI pharmacies in recent years has well supported to growth pattern of ethical generic drugs in Japan. As a large chunk of people trust only branded products, measures are being taken by government to reduce the cost of ethical generics so that Japanese can afford them.

 

The report “Japanese Generic Market Forecast to 2013” covers all the necessary aspects of the generic drugs sector in Japan, emphasizing upon the data reliability and effective presentation. It provides description on the current trends prevailing in the market and illustrates their impact on the industry performance. The report divides the overall generics market in several key sections, in which market size, segment performance, and players’ overview have been analyzed.

 

The report is an outcome of an in-depth research and prudent analysis of the Japanese generics market that emphasize on data reliability and proper content flow. Forecast in key report areas makes use of methods and techniques that seek to present a realistic outlook. Section on key players adds value to the overall market analysis.

For more information visit: http://www.rncos.com/Report/IM170.htm